| 1 | Energy | XLE | +50.1% |
| 2 | Technology | XLK | +31.5% |
| 3 | Healthcare | XLV | +16.4% |
| 4 | Consumer Staples | XLP | +11.9% |
| 5 | Materials | XLB | +11.6% |
| 6 | Industrials | XLI | +6.0% |
| 7 | Real Estate | XLRE | +4.0% |
| 8 | Financials | XLF | +2.0% |
| 9 | Utilities | XLU | -1.0% |
| 10 | Consumer Disc. | XLY | -2.9% |
| 11 | Communication | XLC | -12.0% |
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. …
| Qtr | Date | EPS Est | Act | Δ | YoY | Rev Est | Act | Δ | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Q2 '26 | 7/23/26 | $-0.22 | $-0.19 | +13.6% | -58% | $0.0B | $0.0B | -100.0% | — |
| Q1 '26 | 4/30/26 | $-0.23 | $-0.15 | +34.8% | -114% | $0.0B | $0.0B | -100.0% | — |
| Q4 '25 | 2/23/26 | $-0.10 | $-0.14 | -40.0% | -100% | $0.1B | $0.0B | -100.0% | — |
| Q3 '25 | 10/20/25 | $-0.08 | $-0.13 | -62.5% | -160% | $0.1B | $0.0B | -100.0% | — |
| Q2 '25 | 8/11/25 | $-0.08 | $-0.12 | -50.0% | -140% | — | $0.0B | — | — |
| Q1 '25 | 5/1/25 | $-0.09 | $-0.07 | +22.2% | -17% | — | $0.0B | — | — |